These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20384718)

  • 1. Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms.
    Dracopoulos A; Widjaja E; Raybaud C; Westall CA; Snead OC
    Epilepsia; 2010 Jul; 51(7):1297-304. PubMed ID: 20384718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral MRI abnormalities associated with vigabatrin therapy.
    Pearl PL; Vezina LG; Saneto RP; McCarter R; Molloy-Wells E; Heffron A; Trzcinski S; McClintock WM; Conry JA; Elling NJ; Goodkin HP; de Menezes MS; Ferri R; Gilles E; Kadom N; Gaillard WD
    Epilepsia; 2009 Feb; 50(2):184-94. PubMed ID: 18783433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vigabatrin therapy in infantile spasms.
    Kankirawatana P; Raksadawan N; Balangkura K
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S778-83. PubMed ID: 12403260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy.
    Wheless JW; Carmant L; Bebin M; Conry JA; Chiron C; Elterman RD; Frost M; Paolicchi JM; Donald Shields W; Thiele EA; Zupanc ML; Collins SD
    Epilepsia; 2009 Feb; 50(2):195-205. PubMed ID: 19054414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual fields at school-age in children treated with vigabatrin in infancy.
    Gaily E; Jonsson H; Lappi M
    Epilepsia; 2009 Feb; 50(2):206-16. PubMed ID: 19215279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent.
    Hussain SA; Tsao J; Li M; Schwarz MD; Zhou R; Wu JY; Salamon N; Sankar R
    Epilepsia; 2017 Apr; 58(4):674-682. PubMed ID: 28230253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE; Major P; Halpern E; Thiele EA
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
    Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigabatrin-associated brain abnormalities on MRI and other neurological symptoms in patients with West syndrome.
    Reyes Valenzuela G; Crespo A; Princich J; Fassulo L; Semprino M; Gallo A; Rugilo C; Pociecha J; Calvo A; Caraballo RH
    Epilepsy Behav; 2022 Apr; 129():108606. PubMed ID: 35180571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is visual field constriction in epilepsy patients treated with vigabatrin reversible?
    Schmidt T; Rüther K; Jokiel B; Pfeiffer S; Tiel-Wilck K; Schmitz B
    J Neurol; 2002 Aug; 249(8):1066-71. PubMed ID: 12195456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible magnetic resonance imaging and spectroscopy abnormalities in the course of vigabatrin treatment for West syndrome.
    Thelle T; Gammelgaard L; Hansen JK; Østergaard JR
    Eur J Paediatr Neurol; 2011 May; 15(3):260-4. PubMed ID: 20926323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current role of vigabatrin in infantile spasms.
    Parisi P; Bombardieri R; Curatolo P
    Eur J Paediatr Neurol; 2007 Nov; 11(6):331-6. PubMed ID: 17625936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of West syndrome].
    Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
    Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reversible alterations in the neuroimages associated with vigabatrine treatment in infants with epileptic spasms].
    Fernandez-Garcia MA; Garcia-Penas JJ; Gomez-Martin H; Perez-Sebastian I; Garcia-Esparza E; Sirvent-Cerda S
    Rev Neurol; 2017 Feb; 64(4):169-174. PubMed ID: 28169412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of infantile spasms: results of a population-based study with vigabatrin as the first drug for spasms.
    Granström ML; Gaily E; Liukkonen E
    Epilepsia; 1999 Jul; 40(7):950-7. PubMed ID: 10403219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin-induced MRI changes associated with extrapyramidal symptoms in a child with infantile spasms.
    Schonstedt V; Stecher X; Venegas V; Silva C
    Neuroradiol J; 2015 Oct; 28(5):515-8. PubMed ID: 26306928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms.
    Appleton RE; Peters AC; Mumford JP; Shaw DE
    Epilepsia; 1999 Nov; 40(11):1627-33. PubMed ID: 10565592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of vigabatrin-associated brain abnormalities on MRI: A retrospective and controlled study.
    Xu Y; Wan L; He W; Wang YY; Wang QH; Luo XM; Liu K; Yang XY; Wang J; Shi XY; Yang G; Han F; Gao J; Zou LP
    Epilepsia; 2022 Jan; 63(1):120-129. PubMed ID: 34786694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of infantile spasms with vigabatrin as first-line therapy and in monotherapy: apropos of 70 infants].
    Villeneuve N; Soufflet C; Plouin P; Chiron C; Dulac O
    Arch Pediatr; 1998 Jul; 5(7):731-8. PubMed ID: 9759271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
    Suzuki-Muromoto, S; Uematsu M; Sato H; Numata-Uematsu Y; Nakayama T; Kiluchi A; Kobayashi T; Hino-Fukuyo N; Kure S
    No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.